National Advisory Committee on Immunization (NACI). Interim advisory on measles revaccination of persons with acquired immunodeficiency syndrome (AIDS).
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy*; D000328:Adult; D006801:Humans; D007115:Immunization Schedule; D007117:Immunization, Secondary / Q000009:adverse effects* / Q000379:methods*; D007223:Infant; D008458:Measles Vaccine / Q000008:administration & dosage* / Q000009:adverse effects*; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine / Q000008:administration & dosage* / Q000009:adverse effects*; D017410:Practice Guidelines as Topic; D012411:Rubella Vaccine / Q000008:administration & dosage* / Q000009:adverse effects*; D017778:Vaccines, Combined / Q000008:administration & dosage / Q000009:adverse effects
D008458:Measles Vaccine; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine; D017778:Vaccines, Combined